Consent given pursuant to Sections 14 and 14A for the importation and supply of the therapeutic goods specified - between 12 November 2014 and 10 September 2015

Administered by Department of Health, Disability and Ageing

Legislation au C2014G01938 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

Section 14 and 14A Notice

 

 

On November 12 2014, the delegate of the Secretary of the Department of Health for the purposes of subsection 14 and 14A of the Therapeutic Goods Act 1989 (“the Act”), by application of                 Alphapharm Pty Ltd gave consent to the importation and supply of:

All products in Attachment 1 that do not conform with the requirements of clause 3(2)(l) of the Therapeutic Goods Order No. 69- General requirements for labels for medicines, in that the sponsor details on the labels are those of the previous sponsor (Aspen Pharmacare) instead of the current one Alphapharm Pty Ltd.

The consent is effective from November 12 2014 until September 10 2015.

The delegate of the Secretary has, under subsection 15(1) of the Act, made the consent subject to the following conditions:

 

  1. The labels to which this consent applies are those previously approved for the former sponsor Aspen Pharmacare, and arrangements are in place for the prompt referral of any queries or complaints concerning the products to the current sponsor,                          Alphapharm Pty Ltd.

 

 

 

 

 

 

 

 

 

 

Attachment 1

AUST R No.

Product

Submission Number

152014

adenosine (ASPEN ADENOSINE) 6 mg/2 mL solution for injection vial

PM-2014-03395-1-3

90881

ampicillin (as sodium)(AMPICYN) 1 g powder for injection vial

PM-2014-3396-1-2

29354

ampicillin (as sodium)(AUSTRAPEN) 1 g powder for injection vial

PM-2014-3396-1-2

29349

ampicillin (as sodium)(AUSTRAPEN) 500 mg powder for injection vial

PM-2014-3396-1-2

146755

azithromycin (AZITH)500 mg powder for injection vial

PM-2014-3397-1-2

148218

ceftriaxone sodium (ASPEN CEFTRIAXONE)1 g powder for injection vial

PM-2014-3398-1-2

163200

dexamethasone phosphate (DEXMETHSONE) 4 mg/1 mL (as dexamethasone sodium phosphate) solution for injection vial

PM-2014-3399-1-5

163199

dexamethasone phosphate (DEXMETHSONE) 8 mg/2 mL (as dexamethasone sodium phosphate) solution for injection vial

PM-2014-3399-1-5

144524

ketorolac trometamol (KETORAL INJECTION) 30 mg/1 mL injection syringe

PM-2014-3400-1-1

161750

methylprednisolone (as sodium succinate)(METHYLPRED) 1.0 g powder for injection vial

PM-2014-3401-1-5

145102

methylprednisolone (as sodium succinate)(METHYLPRED) 125 mg powder for injection vial

PM-2014-3401-1-5

145028

methylprednisolone (as sodium succinate)(METHYLPRED) 40 mg powder for injection vial

PM-2014-3401-1-5

145103

methylprednisolone (as sodium succinate) (METHYLPRED) 500 mg powder for injection vial

PM-2014-3401-1-5

144970

piperacillin (as sodium) (TAZOPIP) 4 g/0.5 g, 4 g and tazobactam (as sodium) 0.5 g powder for injection vial

PM-2014-3402-1-2

165350

vecuronium bromide (VECURE) 10 mg powder for injection vial

PM-2014-3403-1-1

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.